专利汇可以提供Probiotics in the treatment of atypical depression and other disorders characterised by hypothalamic pitiuitary-ardrenal axis over activity专利检索,专利查询,专利分析的服务。并且A method of treating a disorder characterized by hypothalamic-pituitary-adrenal axis over-activity comprising administering to a subject a probiotic bacterium.,下面是Probiotics in the treatment of atypical depression and other disorders characterised by hypothalamic pitiuitary-ardrenal axis over activity专利的具体信息内容。
What is claimed is:
This applications claim the benefit of U.S. Provisional patent application Ser. No. 60/468,812, filed May 8, 2003.
The invention is related to the use of probiotics in the treatment of depression and other disorders characterized by hypothalamic-pituitary-adrenal axis over-activity.
Disturbances in hypothalamic-pituitary-adrenal axis (HPA) function are the most consistently demonstrated neuroendocrine abnormalities in major depression. Hypercortisolism and the relative failure to suppress with an overnight dose of dexamethasone are frequently seen. Elevated CSF levels of corticotropin-releasing hormone (CRH)-immunoreactivity, together with blunted CRH-stimulated ACTH release, have also been reported. These changes occur in a setting of adrenal hyperplasia, demonstrable either by CT or MRI imaging (Dinan T Glucocorticoids and the genesis of depressive illness: a psychobiological model. Brit. J. Psychiat. 1984;21:813-829).
There is also evidence in major depression of significant increases in proinflammatory cytokines such as inteleukin-1 (IL1) and IL6 (Maes M The immunoregulatory effects of antidepressants. Hum. Psychopharmacol. 2001; 16:95-103.). Both of these cytokines are know to potently activate the HPA and may play a role in sustaining the HPA activation seen in depression. Effective treatment of depression is accompanied by suppression of proinflammatory cytokines and decreased activation of the HPA.
A method of treating a disorder characterized by hypothalamic-pituitary-adrenal axis over-activity. The method includes administering to a subject a probiotic bacterium.
The invention provides bacterial strains, which improve immunological control and promote appropriate HPA signalling. A deposit of Lactobacillus salivarius strain UCC 118 was made and accorded the accession number NCIMB 40829. A deposit of Lactobacillus paracasei strain AH113 was made and accorded the accession number NCIMB 41097. A deposit of Bifidobacterium infantis strain 35624 was made at the NCIMB and accorded the accession number NCIMB 41003. Our preliminary data suggests these strains in particular have antidepressant action.
The invention relates to the central effects of probiotic bacteria mediated by modulation of the HPA axis. One of the mechanisms whereby probiotic organisms may impact on the HPA is through interaction with the mucosal epithelium and associated lymphoid structures, thereby causing the host to up-regulate and express molecules, which are anti-inflammatory. These would include cytokines such as IL-10 and TGFβ. The present invention is directed toward probiotic strains, which have immuno-regulatory activity and the capacity to decrease HPA activity.
Probiotic effects on serum cytokine levels.
Bifidobacterium infantis 35624 was consumed by 15 healthy volunteers for 3 weeks. Serum cytokine levels were examined pre-and post-consumption. Soluble IL-6 receptor (sIL-6R) and IL-8 levels were significantly decreased following probiotic feeding (
Probiotic effects on PBMC cytokine production.
Peripheral blood mononuclear cells were isolated from healthy donors (n=5) by density gradient centrifugation. PBMCs were stimulated with the probiotic bacterial strain for a 72 hour period at 37° C. At this time culture supernatants were collected, centrifuged, aliquoted and stored at −70° C. until being assessed for IL-10 levels using ELISAs (R&D Systems). Lb. paracasei AH113 stimulated IL-10 secretion from PBMCs (
Probiotic effects on lymph node cytokine production.
Human mesenteric lymph node cells (MLNCs) were isolated from resected specimens and stimulated in vitro with Lb. salivarius UCC118, B. infantis 35624 or Salmonella typhimurium for 3 days. Supernatants were harvested and cytokine levels assessed using ELISAs.
The probiotic bacteria Lb. salivarius UCC118 and B. infantis 35624 stimulated IL-10 and TGFβ production, with no induction of proinflammatory cytokines such as TNFα or IL-12. In contrast, co-incubation with S. typhimurium induced proinflammatory cytokine production with no IL-10 or TGFβ release. Production of IL-10 or TGFβ in vivo following contact with these probiotic bacteria could down-regulate aberrant HPA activity (
Case reports.
Patient 1 was a 36 year old man with a 6 week history of depression. He had previously been depressed 4 years ago. He complained of low mood, anhedonia, early morning wakening, anorexia, loss of 2 kg weight, significant anxiety and negative thoughts about the future. He had a Hamilton depression score of 23.
He had a strong family history of mood disorder. He was medication free at the time of presentation. He was given bifidobacteria in a milk suspension which he took daily for 12 weeks. At the end of week 2 there was a significant improvement in his mental state and by week 3 he was free of symptoms with a Hamilton score of 4.
Patient 2 was a 56 year old woman with a 2 year history of fatigue. All physical investigations were negative and on the basis of her symptoms she was diagnosed using Center for Disease Control criteria as suffering from chronic fatigue syndrome. She failed to respond to a course of cognitive behaviour therapy and a course of a selective serotonin reuptake inhibitor. She was given bifidobacteria in a milk suspension which she took daily for 20 weeks.
By week 6 she noted an improvement in her energy levels. Six weeks later she was walking 2 miles each day. Such exertion would have been impossible on initial presentation. By week 18 she begun working part-time.
Although various specific embodiments of the present invention have been described herein, it is to be understood that the invention is not limited to those precise embodiments and that various changes or modifications can be affected therein by one skilled in the art without departing from the scope and spirit of the invention.
标题 | 发布/更新时间 | 阅读量 |
---|---|---|
益生菌矿物材料复合制剂、矿物材料在制备抑制恶性肿瘤生长药物中的应用 | 2020-05-08 | 341 |
人乳强化剂 | 2020-05-08 | 721 |
矿物类中药和/或无机盐复合制剂在制备辅助防治癌症药物或保健品中的应用 | 2020-05-08 | 635 |
一种代餐粉及其制备方法 | 2020-05-08 | 914 |
一种益生菌粉剂 | 2020-05-08 | 434 |
一种含益生菌果冻粉及其制备方法 | 2020-05-08 | 191 |
一种罗非鱼抗应激中草药益生菌制剂及其制备方法和应用 | 2020-05-08 | 560 |
一种提高水稻抗低温冷害性能的肥料及其制备方法与应用 | 2020-05-08 | 129 |
一种由黑曲霉和酵母菌联合发酵降解凉茶渣并生产益生菌的方法 | 2020-05-08 | 674 |
一种用于益生菌的快速分散装置 | 2020-05-08 | 962 |
高效检索全球专利专利汇是专利免费检索,专利查询,专利分析-国家发明专利查询检索分析平台,是提供专利分析,专利查询,专利检索等数据服务功能的知识产权数据服务商。
我们的产品包含105个国家的1.26亿组数据,免费查、免费专利分析。
专利汇分析报告产品可以对行业情报数据进行梳理分析,涉及维度包括行业专利基本状况分析、地域分析、技术分析、发明人分析、申请人分析、专利权人分析、失效分析、核心专利分析、法律分析、研发重点分析、企业专利处境分析、技术处境分析、专利寿命分析、企业定位分析、引证分析等超过60个分析角度,系统通过AI智能系统对图表进行解读,只需1分钟,一键生成行业专利分析报告。